Toggle navigation
Home
Search
Services
Blog
Contact
About
Innovative Therapies for Rheumatic and Skin Diseases-N01AR2226
University of Cincinnati, Cincinnati, OH, United States
Search grants from University of Cincinnati
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Impaired Risk Avoidance in Bipolar Disorder and Substance Use Disorders
Medullary Reticular Neuron Depletion - Autonomic Failure & Multiple System Atrophy
Early Drug Evaluation in Neurotic Outpatients
Modeling of Cognition
Pathophysiology of Edema
Recently added grants:
The impact of HIV-1 infection and its treatment on gastrointestinal B cells
GPCR-mediated pathways for regulation of intestinal lymphatic function
Mouse Metabolic Function & Phenotyping Core
Lymphatic remodeling and transport of dietary fats in short gut syndrome
Cytometry & Cell Sorting Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research and Development Contracts (N01)
Project #
N01AR022264-003
Application #
6828856
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Cincinnati
Department
Type
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Related projects
NIH 2005
N01 AR
Gabapentin in the Treatment of Fibromyalgia-264022264
/ University of Cincinnati
NIH 2004
N01 AR
Innovative Therapies for Rheumatic and Skin Diseases-264022264
/ University of Cincinnati
NIH 2003
N01 AR
Innovative Therapies for Rheumatic and Skin Diseases-N01AR2226
/ University of Cincinnati
NIH 2002
N01 AR
Innovative Therapies for Rheumatic and Skin Diseases-N01AR2226
/ University of Cincinnati
Publications
Arnold, Lesley M; Goldenberg, Don L; Stanford, Sharon B et al.
(2007)
Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial.
Arthritis Rheum 56:1336-44
Comments
Be the first to comment on this grant